Principal Financial Group Inc. lifted its stake in Heska Co. (NASDAQ:HSKA – Get Rating) by 0.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,374 shares of the medical research company’s stock after acquiring an additional 154 shares during the period. Principal Financial Group Inc. owned 0.59% of Heska worth $4,001,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. Signaturefd LLC lifted its stake in shares of Heska by 146.3% in the 4th quarter. Signaturefd LLC now owns 399 shares of the medical research company’s stock worth $25,000 after acquiring an additional 237 shares during the period. Point72 Hong Kong Ltd bought a new stake in shares of Heska in the 1st quarter worth approximately $57,000. Quantbot Technologies LP raised its holdings in shares of Heska by 245.6% in the 3rd quarter. Quantbot Technologies LP now owns 508 shares of the medical research company’s stock worth $37,000 after purchasing an additional 361 shares in the last quarter. UBS Group AG raised its holdings in shares of Heska by 83.1% in the 3rd quarter. UBS Group AG now owns 1,703 shares of the medical research company’s stock worth $124,000 after purchasing an additional 773 shares in the last quarter. Finally, Mutual of America Capital Management LLC raised its holdings in shares of Heska by 11.7% in the 3rd quarter. Mutual of America Capital Management LLC now owns 2,024 shares of the medical research company’s stock worth $148,000 after purchasing an additional 212 shares in the last quarter. 99.01% of the stock is owned by institutional investors and hedge funds.
Heska Stock Up 0.0 %
HSKA stock opened at $119.73 on Thursday. Heska Co. has a 52-week low of $57.83 and a 52-week high of $119.87. The company’s 50 day simple moving average is $113.80 and its 200-day simple moving average is $88.85. The company has a debt-to-equity ratio of 0.23, a current ratio of 5.64 and a quick ratio of 4.12. The firm has a market capitalization of $1.31 billion, a P/E ratio of -62.04 and a beta of 1.60.
Analyst Ratings Changes
A number of research firms recently commented on HSKA. Piper Sandler dropped their target price on shares of Heska from $165.00 to $150.00 in a report on Thursday, March 2nd. Alliance Global Partners downgraded shares of Heska from a “buy” rating to a “neutral” rating in a report on Monday, April 3rd. Morgan Stanley boosted their target price on shares of Heska from $58.00 to $120.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 4th. Finally, StockNews.com assumed coverage on shares of Heska in a report on Wednesday. They issued a “hold” rating on the stock. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $137.25.
About Heska
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland.
Read More
- Get a free copy of the StockNews.com research report on Heska (HSKA)
- A.I. ETF Sold Out Of Monster Energy, Three Ways To Look At It
- Don’t Worry; Sportsman’s Warehouse Will Get Cheaper
- Trinseo’s Dip, Has Something Changed Or Is It Just A Down Cycle
- The Most Upgraded Stocks From The Q1 Earnings Season
- What U-Haul Earnings Are Showing, Heading Up?
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.
